Royal Bank of Canada lowers Bio-Techne (NASDAQ:TECH) price target to USD 70.00

Bio-Techne (NASDAQ:TECH – Free Report) The price target was cut by Royal Bank of Canada from $72.00 to $70.00 in a research note published on Thursday, Benzinga reports. Royal Bank of Canada currently has a sector perform rating on the…